Carrier-mediated or specialized transport of drugs across the blood-brain barrier.

Abstract:

:In the drug development process, it remains a difficult task to regulate the entry of the drugs. However, recent progress in studies of the transporter-mediated influx and efflux of endogenous and exogenous compounds, including synthetic drugs, across the blood-brain barrier (BBB) is beginning to provide a rational basis for controlling drug distribution to the brain. This paper describes mechanisms established in the last decade for carrier-mediated influx and efflux of drugs and endocytosis of biologically active peptides across the BBB. The transport systems at the BBB described here are the uptake transporters for nutrients, such as amino acids and hexoses, monocarboxylates, amines, carnitine and glutathione and efflux transporters, such as P-glycoprotein and multiple organic anion transporters. Delivery of cationized peptides across the BBB via adsorptive-mediated endocytosis is also described. By utilizing such highly specific transport mechanisms, it should be possible to establish strategies to regulate the entry of candidate drugs, including peptides, into the brain.

journal_name

Adv Drug Deliv Rev

authors

Tsuji A,Tamai I I

doi

10.1016/s0169-409x(98)00084-2

subject

Has Abstract

pub_date

1999-04-05 00:00:00

pages

277-290

issue

2-3

eissn

0169-409X

issn

1872-8294

pii

S0169-409X(98)00084-2

journal_volume

36

pub_type

杂志文章
  • Polymer genomics: an insight into pharmacology and toxicology of nanomedicines.

    abstract::Synthetic polymers and nanomaterials display selective phenotypic effects in cells and in the body signal transduction mechanisms involved in inflammation, differentiation, proliferation, and apoptosis. When physically mixed or covalently conjugated with cytotoxic agents, bacterial DNA or antigens, polymers can drasti...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2006.09.019

    authors: Kabanov AV

    更新日期:2006-12-30 00:00:00

  • Cell encapsulation: Overcoming barriers in cell transplantation in diabetes and beyond.

    abstract::Cell-based therapy is emerging as a promising strategy for treating a wide range of human diseases, such as diabetes, blood disorders, acute liver failure, spinal cord injury, and several types of cancer. Pancreatic islets, blood cells, hepatocytes, and stem cells are among the many cell types currently used for this ...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2018.04.018

    authors: Farina M,Alexander JF,Thekkedath U,Ferrari M,Grattoni A

    更新日期:2019-01-15 00:00:00

  • Targeting polymer therapeutics to bone.

    abstract::An aging population in the developing world has led to an increase in musculoskeletal diseases such as osteoporosis and bone metastases. Left untreated many bone diseases cause debilitating pain and in the case of cancer, death. Many potential drugs are effective in treating diseases but result in side effects prevent...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2012.01.012

    authors: Low SA,Kopeček J

    更新日期:2012-09-01 00:00:00

  • Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics.

    abstract::Hepatocellular carcinoma (HCC) remains one of the most lethal forms of cancer in the world. In this arena, utilities of microRNA (miRNA) as a sophisticated tool, in therapeutics and diagnostics, remains a prime focus among the leading researchers. It is well known that viral hepatitis, chronic alcoholism and metabolic...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2014.10.029

    authors: Yang N,Ekanem NR,Sakyi CA,Ray SD

    更新日期:2015-01-01 00:00:00

  • Nanocarriers for delivery of platinum anticancer drugs.

    abstract::Platinum based anticancer drugs have revolutionized cancer chemotherapy, and continue to be in widespread clinical use especially for management of tumors of the ovary, testes, and the head and neck. However, several dose limiting toxicities associated with platinum drug use, partial anti-tumor response in most patien...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2013.09.014

    authors: Oberoi HS,Nukolova NV,Kabanov AV,Bronich TK

    更新日期:2013-11-01 00:00:00

  • Molecular imprinting within hydrogels.

    abstract::Hydrogels have been used primarily in the pharmaceutical field as carriers for delivery of various drugs, peptides and proteins. These systems have included stimuli-responsive gels that exhibit reversible swelling behavior and hence can show modulated release in response to external stimuli such as pH, temperature, io...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0169-409x(01)00246-0

    authors: Byrne ME,Park K,Peppas NA

    更新日期:2002-01-17 00:00:00

  • Microfabrication technologies for oral drug delivery.

    abstract::Micro-/nanoscale technologies such as lithographic techniques and microfluidics offer promising avenues to revolutionalize the fields of tissue engineering, drug discovery, diagnostics and personalized medicine. Microfabrication techniques are being explored for drug delivery applications due to their ability to combi...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2011.11.013

    authors: Sant S,Tao SL,Fisher OZ,Xu Q,Peppas NA,Khademhosseini A

    更新日期:2012-05-01 00:00:00

  • Anticancer therapy using glucuronate modified long-circulating liposomes.

    abstract::Since conventional liposomes tend to be trapped by the reticuroendothelial systems (RES), their use as drug carriers is limited when the targets are not RES cells. Therefore, many attempts have been made to avoid the RES-trapping of liposomes. Favorable results were obtained by a modification of liposomes with a glucu...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章

    doi:10.1016/s0169-409x(99)00040-x

    authors: Oku N

    更新日期:1999-11-10 00:00:00

  • Advancement in integrin facilitated drug delivery.

    abstract::The research of integrin-targeted anticancer agents has recorded important advancements in ingenious design of delivery systems, based either on the prodrug approach, or on nanoparticle carriers, but for now, none of these has reached a clinical stage of development. Past work in this area has been extensively reviewe...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2015.12.001

    authors: Arosio D,Casagrande C

    更新日期:2016-02-01 00:00:00

  • Microdialysis assessment of drug delivery systems for vitreoretinal targets.

    abstract::Posterior segment drug delivery challenges inherent in the treatment of many sight-threatening diseases have become increasingly apparent. Therapeutic interventions for ocular diseases such as neovascular retinopathies, inflammatory and/or infectious diseases may involve drug delivery to vitreoretinal targets. An impo...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2005.09.008

    authors: Duvvuri S,Rittenhouse KD,Mitra AK

    更新日期:2005-12-13 00:00:00

  • Formulation and delivery issues for monoclonal antibody therapeutics.

    abstract::Antibodies can have exquisite specificity of target recognition and thus generate highly selective outcomes following their systemic administration. While antibodies can have high specificity, the doses required to treat patients, particularly for a chronic condition, are typically large. Fortunately, advances in prod...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2006.03.011

    authors: Daugherty AL,Mrsny RJ

    更新日期:2006-08-07 00:00:00

  • Disulfide bridge based PEGylation of proteins.

    abstract::PEGylation is a clinically proven strategy for increasing the therapeutic efficacy of protein-based medicines. Our approach to site-specific PEGylation exploits the thiol selective chemistry of the two cysteine sulfur atoms from an accessible disulfide. It involves two key steps: (1) disulfide reduction to release the...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2007.06.014

    authors: Brocchini S,Godwin A,Balan S,Choi JW,Zloh M,Shaunak S

    更新日期:2008-01-03 00:00:00

  • The transport of antiepileptic drugs by P-glycoprotein.

    abstract::Epilepsy is the most common serious chronic neurological disorder. Current data show that one-third of patients do not respond to anti-epileptic drugs (AEDs). Most non-responsive epilepsy patients are resistant to several, often all, AEDs, even though the drugs differ from each other in pharmacokinetics, mechanisms of...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2011.12.003

    authors: Zhang C,Kwan P,Zuo Z,Baum L

    更新日期:2012-07-01 00:00:00

  • 50years of oral lipid-based formulations: Provenance, progress and future perspectives.

    abstract::Lipid based formulations (LBF) provide well proven opportunities to enhance the oral absorption of drugs and drug candidates that sit close to, or beyond, the boundaries of Lipinski's 'rule-of-five' chemical space. Advantages in permeability, efflux and presystemic metabolism are evident; however, the primary benefit ...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2016.04.007

    authors: Feeney OM,Crum MF,McEvoy CL,Trevaskis NL,Williams HD,Pouton CW,Charman WN,Bergström CAS,Porter CJH

    更新日期:2016-06-01 00:00:00

  • RNA interference for improving the outcome of islet transplantation.

    abstract::Islet transplantation has the potential to cure type 1 diabetes. Despite recent therapeutic success, it is still not common because a large number of transplanted islets get damaged by multiple challenges including instant blood mediated inflammatory reaction, hypoxia/reperfusion injury, inflammatory cytokines, and im...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2010.11.003

    authors: Li F,Mahato RI

    更新日期:2011-01-01 00:00:00

  • Lanthanide-doped upconverting luminescent nanoparticle platforms for optical imaging-guided drug delivery and therapy.

    abstract::Lanthanide-doped upconverting luminescent nanoparticles (UCNPs) are promising materials for optical imaging-guided drug delivery and therapy due to their unique optical and chemical properties. UCNPs absorb low energy near-infrared (NIR) light and emit high-energy shorter wavelength photons. Their special features all...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2012.05.007

    authors: Shen J,Zhao L,Han G

    更新日期:2013-05-01 00:00:00

  • Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.

    abstract::Mesenchymal stem cells (MSC) are a promising tool for cell therapy, either through direct contribution to the repair of bone, tendon and cartilage or as an adjunct therapy through protein production and immune mediation. They are an attractive vehicle for cellular therapies due to a variety of cell intrinsic and envir...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2010.09.013

    authors: Meyerrose T,Olson S,Pontow S,Kalomoiris S,Jung Y,Annett G,Bauer G,Nolta JA

    更新日期:2010-09-30 00:00:00

  • Matrices and scaffolds for DNA delivery in tissue engineering.

    abstract::Regenerative medicine aims to create functional tissue replacements, typically through creating a controlled environment that promotes and directs the differentiation of stem or progenitor cells, either endogenous or transplanted. Scaffolds serve a central role in many strategies by providing the means to control the ...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2007.03.017

    authors: De Laporte L,Shea LD

    更新日期:2007-05-30 00:00:00

  • Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies.

    abstract::Clinical development of orally active peptide drugs has been restricted by their unfavorable physicochemical properties, which limit their intestinal mucosal permeation and their lack of stability against enzymatic degradation. Successful oral delivery of peptides will depend, therefore, on strategies designed to alte...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章

    doi:10.1016/s0169-409x(97)00045-8

    authors: T Borchardt R,Jeffrey Aubé,Siahaan TJ,Gangwar S,Pauletti GM

    更新日期:1997-09-15 00:00:00

  • Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.

    abstract::Prior to the introduction of troglitazone, it had been more than 30 years since the last significant improvement in antidiabetic therapy. In view of the pressing need for more effective oral agents for the treatment of Type 2 diabetes mellitus, troglitazone was granted priority review by the FDA and was launched in th...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0169-409x(02)00093-5

    authors: Parker JC

    更新日期:2002-11-05 00:00:00

  • The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics.

    abstract::Microdialysis can give simultaneous information on unbound drug concentration-time profiles in brain extracellular fluid (ECF) and blood, separating the information on blood-brain barrier (BBB) processes from confounding factors such as binding to brain tissue or proteins in blood. This makes microdialysis suitable fo...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0169-409x(00)00109-5

    authors: Hammarlund-Udenaes M

    更新日期:2000-12-15 00:00:00

  • Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA.

    abstract::Nucleic acids have gained a lot of interest for the treatment of ocular diseases. The first to enter in clinic has been Vitravene an antisense oligonucleotide for the treatment of cytomegalovirus (CMV) infection and more recently, research on aptamers have led to the marketing of anti-vascular endothelial growth facto...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2006.07.020

    authors: Fattal E,Bochot A

    更新日期:2006-11-15 00:00:00

  • Mitochondrial trifunctional protein defects: clinical implications and therapeutic approaches.

    abstract::The mitochondrial trifunctional protein (MTP) is a heterotrimeric protein that consists of four alpha-subunits and four beta-subunits and catalyzes three of the four chain-shortening reactions in the mitochondrial beta-oxidation of long-chain fatty acids. Families with recessively inherited MTP defects display a spect...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2008.04.014

    authors: Rector RS,Payne RM,Ibdah JA

    更新日期:2008-10-01 00:00:00

  • Mitochondrial DNA metabolism targeting drugs.

    abstract::Numerous drugs are known to deplete mitochondrial DNA (mtDNA) from mammalian cells. These include DNA polymerase gamma and type II topoisomerase inhibitors, lipophilic cationic compounds, and DNA intercalating and non intercalating agents. The effects of these drugs on mtDNA metabolism will be discussed and potential ...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0169-409x(01)00133-8

    authors: Rowe TC,Weissig V,Lawrence JW

    更新日期:2001-07-02 00:00:00

  • Controlling timing and location in vaccines.

    abstract::Vaccines are one of the most powerful technologies supporting public health. The adaptive immune response induced by immunization arises following appropriate activation and differentiation of T and B cells in lymph nodes. Among many parameters impacting the resulting immune response, the presence of antigen and infla...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2020.06.019

    authors: Irvine DJ,Aung A,Silva M

    更新日期:2020-01-01 00:00:00

  • The role of mucus on drug transport and its potential to affect therapeutic outcomes.

    abstract::A layer of mucus covers the surface of all wet epithelia throughout the human body. Mucus is a hydrogel mainly composed of water, mucins (glycoproteins), DNA, proteins, lipids, and cell debris. This complex composition yields a tenacious viscoelastic hydrogel that lubricates and protects the exposed epithelia from ext...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2017.10.009

    authors: Murgia X,Loretz B,Hartwig O,Hittinger M,Lehr CM

    更新日期:2018-01-15 00:00:00

  • Biopolymer stereocomplexes.

    abstract::A polymer stereocomplex is defined as a stereoselective interaction between two complementing stereoregular polymers, that interlock and form a new composite, demonstrating altered physical properties in comparison to the parent polymers. The main interactions, resulting in the complexation, are suggested to rely on s...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0169-409x(03)00042-5

    authors: Slager J,Domb AJ

    更新日期:2003-04-25 00:00:00

  • Overcoming drug resistance by regulating nuclear receptors.

    abstract::Drug resistance involves multiple mechanisms. Multidrug resistance (MDR) is the leading cause of treatment failure in cancer therapy. Elevated levels of MDR proteins [members of the ATP-binding cassette (ABC) transporter family] increase cellular efflux and decrease the effectiveness of chemotherapeutic agents. As a s...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2010.07.008

    authors: Chen T

    更新日期:2010-10-30 00:00:00

  • Responsive triggering systems for delivery in chronic wound healing.

    abstract::Non-communicable diseases including cancer, cardiovascular disease, diabetes, and neuropathy are chronic in nature. Treatment of these diseases with traditional delivery systems is limited due to lack of site-specificity, non-spatiotemporal release and insufficient doses. Numerous responsive delivery systems which res...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2018.02.008

    authors: Morey M,Pandit A

    更新日期:2018-04-01 00:00:00

  • Bench-to-bedside translation of dendrimers: Reality or utopia? A concise analysis.

    abstract::Nanomedicine, which is an application of nanotechnologies in healthcare is developed to improve the treatments and lives of patients suffering from a range of disorders and to increase the successes of drug candidates. Within the nanotechnology universe, the remarkable unique and tunable properties of dendrimers have ...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2017.11.007

    authors: Mignani S,Rodrigues J,Tomas H,Roy R,Shi X,Majoral JP

    更新日期:2018-01-01 00:00:00